Nuclear factor kappaB signaling in opioid functions and receptor gene expression
- PMID: 18040804
- PMCID: PMC3446243
- DOI: 10.1007/s11481-006-9028-0
Nuclear factor kappaB signaling in opioid functions and receptor gene expression
Abstract
Opiates are the most powerful of all known analgesics. The prototype opiate morphine has been used as a painkiller for several thousand years. Chronic usage of opiates not only causes drug tolerance, dependence, and addiction, but also suppresses immune functions and affects cell proliferation and cell survival. The diverse functions of opiates underscore the complexity of opioid receptor signaling. Several downstream signaling effector systems, including adenylyl cyclase, mitogen-activated protein kinase, Ca2+ channels, K+ channels, and phosphatidylinositol 3-kinase/Akt, have been identified to be critical in opioid functions. Nuclear factor-kappaB (NF-kappaB), one of the most diverse and critical transcription factors, is one of the downstream molecules that may either directly or indirectly transmit the receptor-mediated upstream signals to the nucleus, resulting in the regulation of the NF-kappaB-dependent genes, which are critical for the opioid-induced biological responses of neuronal and immune cells. In this minireview, we focus on current understanding of the involvement of NF-kappaB signaling in opioid functions and receptor gene expression in cells.
Figures
References
-
- Ai W, Gong J, Yu L. MAP kinase activation by mu opioid receptor involves phosphatidylinositol 3-kinase but not the cAMP/PKA pathway. FEBS Lett. 1999;456:196–200. - PubMed
-
- Augustin LB, Felsheim RF, Min BH, Fuchs SM, Fuchs JA, Loh HH. Genomic structure of the mouse delta opioid receptor gene. Biochem Biophys Res Commun. 1995;207:111–119. - PubMed
-
- Azuma Y, Ohura K. Endomorphins 1 and 2 inhibit IL-10 and IL-12 production and innate immune functions, and potentiate NF-kappaB DNA binding in THP-1 differentiated to macrophage-like cells. Scand J Immunol. 2002;56:260–269. - PubMed
-
- Baeuerle PA, Baltimore D. NF-kappa B: ten years after. Cell. 1996;87:13–20. - PubMed
-
- Barger SW, Horster D, Furukawa K, Goodman Y, Krieglstein J, Mattson MP. Tumor necrosis factors alpha and beta protect neurons against amyloid beta-peptide toxicity: evidence for involvement of a kappa B-binding factor and attenuation of peroxide and Ca2+ accumulation. Proc Natl Acad Sci USA. 1995;92:9328–9332. - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- DA007339/DA/NIDA NIH HHS/United States
- R01 DA016674/DA/NIDA NIH HHS/United States
- K05 DA000513/DA/NIDA NIH HHS/United States
- R01 DA000564/DA/NIDA NIH HHS/United States
- R56 DA000564/DA/NIDA NIH HHS/United States
- K05-DA00513/DA/NIDA NIH HHS/United States
- R01 DA001583/DA/NIDA NIH HHS/United States
- DA011806/DA/NIDA NIH HHS/United States
- DA000564/DA/NIDA NIH HHS/United States
- P50 DA011806/DA/NIDA NIH HHS/United States
- R01 DA007339/DA/NIDA NIH HHS/United States
- K05 DA070554/DA/NIDA NIH HHS/United States
- K05-DA70554/DA/NIDA NIH HHS/United States
- DA016674/DA/NIDA NIH HHS/United States
- DA001583/DA/NIDA NIH HHS/United States
LinkOut - more resources
Full Text Sources
Miscellaneous
